Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

655 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erratum to: "Racial Disparities in Opioid Use and Lumbar Spine Surgery for Chronic Pain and in Pain and Function Over 3 Years: A Retrospective Cohort Study," The Journal of Pain, Volume 25, Issue 3, March 2024, Pages 659-671.
Licciardone JC, Miller CL, Nazzal AJ, Hernandez CT, Nguyen LH, Aryal S. Licciardone JC, et al. Among authors: nguyen lh. J Pain. 2024 May;25(5):104499. doi: 10.1016/j.jpain.2024.02.013. J Pain. 2024. PMID: 38679451 No abstract available.
Identification of differentially expressed genes and metabolism signaling pathway in the spleen of broilers supplemented with probiotic Bacillus spp.
Truong AD, Tran HTT, Thi Nguyen H, Thi Chu N, Phan L, Thi Phan H, Thi Pham N, Nguyen VH, Nguyen LH, Pham DK, Ho PH, Vu Dang H. Truong AD, et al. Among authors: nguyen lh. Vet Immunol Immunopathol. 2024 Apr 18;272:110755. doi: 10.1016/j.vetimm.2024.110755. Online ahead of print. Vet Immunol Immunopathol. 2024. PMID: 38643554
Hemojuvelin mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3.
Dogan DY, Urzica EI, Hornung I, Kastl P, Oguama D, Fette FM, Nguyen LH, Rosenbauer F, Zacharowski K, Klingmüller U, Gradhand E, von Knethen A, Popp R, Fleming I, Schrader L, Steinbicker AU. Dogan DY, et al. Among authors: nguyen lh. Blood Adv. 2024 Apr 8:bloodadvances.2023012322. doi: 10.1182/bloodadvances.2023012322. Online ahead of print. Blood Adv. 2024. PMID: 38588481
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
655 results